Table 2.
Patients | Subtype | CD2 (%) | CD3 (%) | CD4 (%) | CD5 (%) | CD8 (%) | CD25 (%) | CD30 (%) |
---|---|---|---|---|---|---|---|---|
1 | Acute (PB) | 93.1 | 89.3 | 90.1 | 93.1 | 4.5 | 88.7 | 74.1 |
2 | Acute (PB) | 98.3 | 79.3 | 85.1 | 70.6 | 6.4 | 45.3 | 7.2 |
2 | Acute (spleen) | 100.0 | 96.0 | 99.3 | 57.3 | 1.6 | 94.7 | 27.2 |
3 | Acute (PB) | 84.3 | 88.7 | 96.0 | 89.8 | 6.0 | 68.4 | 27.2 |
4 | Acute (LN) | 94.7 | 20.2 | 52.5 | 12.9 | 24.0 | 28.4 | 10.1 |
5 | Acute (PB) | 93.9 | 69.7 | 84.8 | 14.5 | 3.3 | 66.5 | 33.3 |
6 | Acute (PB) | 92.3 | 60.6 | 89.3 | 76.6 | 5.5 | 82.9 | 16.9 |
8 | Lymphoma (LN) | 100.0 | 100.0 | 99.8 | 86.9 | 40.2 | 98.0 | 11.4 |
9 | Lymphoma (LN) | 95.0 | 91.9 | 93.8 | 91.7 | 90.0 | 84.7 | 19.6 |
10 | Lymphoma (LN) | 90.3 | 91.1 | 24.8 | 98.7 | 35.0 | 86.6 | 45.4 |
LN, lymph node; PB, peripheral blood.